Efficacy of ND0612, a 24-hour Subcutaneous Levodopa/Carbidopa Infusion for People with Parkinson’s Disease Experiencing Motor Fluctuations: Subgroup-analyses from a Randomized, Controlled Phase 3 Study (S30.008)

To evaluate the efficacy and safety of 24-hour subcutaneous levodopa/carbidopa infusion with investigational ND0612 for different subgroups of people with Parkinson's disease (PwP) experiencing motor fluctuations.